Search Results 8501-8510 of 42618 for oral

1. A Study to Assess the Effectiveness and Safety of Golimumab in Pediatric Participants With Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

   ... oral or intravenous corticosteroids, 6-mercaptopurine, methotrexate or azathioprine OR must either have or have had a history of corticosteroid dependency ...

2. Phase 1 Study to Evaluate the Safety of ATA188 in Subjects With Progressive and Relapsing-Remitting Multiple Sclerosis - Mayo Clinic

   ... oral contraceptives, some intrauterine contraceptive devices, sexual abstinence, or a vasectomized partner, and/or unwilling to refrain from donating eggs ...

3. Cleft lip and cleft palate - Care at Mayo Clinic

   Plastic surgeons direct the team, which may include specialists in ear, nose and throat (ENT) and oral surgery, orthodontics, speech, hearing, psychology ...

4. Rheumatoid Arthritis Clinical Trials

   The overall objective of this study is to examine if the strategy starting of the addition of a tsDMARD, oral targeted molecule medications will lead to ...

5. Tongue cancer - Doctors and departments - Mayo Clinic

   Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating ...

6. Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine - Mayo Clinic

   Previous participation in a clinical study of IV or oral rigosertib. Anemia due to factors other than MDS (including hemolysis or gastrointestinal [GI] ...

7. S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer - Mayo Clinic

   Patients must not be taking oral glucocorticoids at the time of registration. Patients must not be planning to receive concomitant biologic therapy ...

8. A Randomized, Placebo-controlled, Double-blind, Multi-center Phase 2/3 Trial To Assess Efficacy And Safety Of Octreotide Subcutaneous Depot (CAM2029) In Patients With Symptomatic Polycystic Liver Disease - Mayo Clinic

   Use of oral contraceptives or estrogen supplementation within 3 months before screening. Poorly controlled diabetes (hemoglobin A1c ≥ 10%) at screening ...

9. A Study To Evaluate The Safety And Effectiveness Of TT-00420 In Adults With Advanced Cholangiocarcinoma - Mayo Clinic

   Inability to swallow or tolerate oral medication. Has a history or current evidence of any condition, therapy, or laboratory abnormality that, in the ...

10. Phase 2 Study Of VGT-309 In Lung Cancer - Mayo Clinic

    - Oral, injectable, implantable, intravaginal, or transdermal hormonal contraceptives, or - Intrauterine device or intrauterine hormone-releasing system